Thursday, Jan 25, 2024 · SEC filings

What the smart money revealed on Jan 25

Real insider buys27insiders · $7.86M
Real insider sales45insiders · $66.5M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

444 insider filings came in. We hid 26 planned (10b5-1) sellers and 328 people whose filings were routine, like grants and tax withholding.

group

11 insiders at Community Trust Bancorp (CTBI) bought $249K of stock

Roles: CEO, President, CFO, Executive VP. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 2–24
$249K
trending_up

Edgewise Therapeutics (EWTX) Director Peter Thompson bought $5M

454,545 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 23
$5M
trending_up

CalciMedica (CALC) Director Fred Middleton bought $2.51M

679,384 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 23
$2.51M
trending_down

Kb Home (KBH) President and CEO Jeffrey Mezger sold $15.1M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 2.98M shares directly.

Real sale Form 4 Traded Jan 23–25
$15.1M
trending_down

Kb Home (KBH) EVP and CFO Jeff Kaminski sold $11.5M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 134,734 shares directly.

Real sale Form 4 Traded Jan 23–25
$11.5M
trending_down

Global Crossing Airlines Group (JETMF) Director Cordia Harrington sold $8.45M

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Jan 23
$8.45M
Show 14 more real buys
Show 42 more real sales
IRON Disc Medicine · Director Kevin Bitterman · Traded Jan 23
$6.93M
MS Morgan Stanley · Executive Chairman James Gorman · Traded Jan 25
$4.4M
TRV Travelers Companies · EVP and Pres. Jeffrey Klenk · Traded Jan 24
$3.64M
GS Goldman Sachs Group · Chief Legal Officer Kathryn Ruemmler · Traded Jan 23
$2.76M
TEAM Atlassian · Co-CEO Michael Cannon-Brookes · Traded Jan 24
$2.02M
TEAM Atlassian · Co-CEO Scott Farquhar · Traded Jan 24
$2.02M
SNX TD SYNNEX · Americas President Michael Urban · Traded Jan 23–24
$1.71M
GS Goldman Sachs Group · Chief Accounting Officer Sheara Fredman · Traded Jan 23
$1.63M
SLB Schlumberger Limited · EVP Mogharbel Al · Traded Jan 23
$1.5M
SLB Schlumberger Limited · Chief Accounting Officer Howard Guild · Traded Jan 24
$1.18M
SLB Schlumberger Limited · VP and Treasurer Kevin Fyfe · Traded Jan 25
$1.05M
SYM Symbotic · Chief Strategy Officer William Boyd III · Traded Jan 24–25
$560K
EYPT EyePoint Pharmaceuticals · Chief Medical Officer Dario Paggiarino · Traded Jan 23–24
$410K
SYM Symbotic · Senior Vice President Michael Dunn · Traded Jan 24–25
$315K
MAIN Main Street Capital · Managing Director Nicholas Meserve · Traded Dec 20 · Filed late
$258K
SNV Synovus Financial · Director Tim Bentsen · Traded Jan 24
$180K
FDMT 4D Molecular Therapeutics · CEO David Kirn · Traded Jan 23
$105K
COUR Coursera · SVP Kenneth Hahn · Traded Jan 23
$92K
TSPH TuSimple · CEO Cheng Lu · Traded Jan 23–24
$90.3K
UNTY Unity Bancorp · Director Mary Gross · Traded Jan 23
$87.9K
CBSH Commerce Bancshares · Executive Vice President John Handy · Traded Jan 24
$82.6K
UNTY Unity Bancorp · Director Mortgage Lending/SVP Vincent Geraci · Traded Jan 23
$75.3K
TVTX Travere Therapeutics · CEO Eric Dube · Traded Jan 23
$70.5K
CBSH Commerce Bancshares · Senior Vice President Patricia Kellerhals · Traded Jan 24
$40.1K
CBSH Commerce Bancshares · Senior Vice President David Roller · Traded Jan 24
$39.6K
NUS Nu Skin Enterprises · Director Andrew Lipman · Traded Jan 25
$37.1K
INDB Independent Bank · Director Eileen Miskell · Traded Jan 24
$24.5K
ZVIA Zevia PBC · President and CEO Amy Taylor · Traded Jan 24
$20.5K
TVTX Travere Therapeutics · Senior Vice President William Rote · Traded Jan 23
$18.5K
TVTX Travere Therapeutics · SVP Elizabeth Reed · Traded Jan 23
$18.5K
TVTX Travere Therapeutics · Chief Commercial Officer Peter Heerma · Traded Jan 23
$14.1K
TSPH TuSimple · CFO Eric Tapia · Traded Jan 23–24
$8.78K
TVTX Travere Therapeutics · SVP Sandra Calvin · Traded Jan 23
$8.25K
TVTX Travere Therapeutics · CFO Christopher Cline · Traded Jan 23
$7.74K
ZVIA Zevia PBC · SVP Lorna Simms · Traded Jan 24
$7.16K
KLRS Allovir · CEO Diana Brainard · Traded Jan 23
$6.37K
ZVIA Zevia PBC · Chief Accounting Officer Hany Mikhail · Traded Jan 24
$5.01K
KLRS Allovir · Officer Title: President and CFO Vikas Sinha · Traded Jan 23
$2.15K
KLRS Allovir · General Counsel Edward Miller · Traded Jan 23
$872
KLRS Allovir · Chief Accounting Officer Brett Hagen · Traded Jan 23
$604
GOEV Canoo · SVP and CAO Ramesh Murthy · Traded Jan 24
$219
EBTC Enterprise Bancorp · Director Jacqueline Moloney · Traded Jul 18 · Filed late
$25

13F season

Holdings as of Dec 31, 2023 are due Feb 14

49 funds have filed so far. 40 filed for the quarter before.

Biggest real insider buys, Jan 19–25

Open-market buys by officers and directors, filed in the 7 days up to Jan 25.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist